Cystic Fibrosis News and Research

Latest Cystic Fibrosis News and Research

Clinical trial to test the safety, efficacy of bacteriophages for treating P. aeruginosa infections in CF patients

Cystic fibrosis (CF) is an inherited disorder that causes severe damage to the lungs and other organs in the body.

11 Oct 2022

Early-stage clinical trial evaluating bacteriophage therapy in adults with cystic fibrosis begins

Enrollment has begun in an early-stage clinical trial evaluating bacteriophage therapy in adults with cystic fibrosis (CF) who carry Pseudomonas aeruginosa (P. aeruginosa) in their lungs.

4 Oct 2022

Immune cell defect tied to the risk of developing rare bacterial infection

Everyone breathes in Mycobacterium avium complex (MAC) bacteria from time to time, but most people don't get sick.

3 Oct 2022

Learning health system approach offers a powerful route to improving NHS efficiency, report suggests

Researchers are calling on policy makers to support the use of data-driven learning health systems to deliver a step change in the NHS's ability to improve patient care.

30 Sep 2022

Vitamin supplements can benefit cystic fibrosis patients, study suggests

Cystic fibrosis patients who supplement their diet with vitamin C can also derive greater benefit from another antioxidant, vitamin E, resulting in a reduction in damaging inflammation, a study led by Oregon State University suggests.

28 Sep 2022

Investing in the next generation of researchers, Beckman Coulter Life Sciences announces call for grant applications

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, announces its continuing commitment to the next generation of researchers and scientists with a call for registrations for its SPRI Grants for Genomic Research.

From Beckman Coulter Life Sciences 27 Sep 2022

Newborns get routine heel blood tests, but should states keep those samples

Close to 4 million babies are born in the United States every year, and within their first 48 hours nearly all are pricked in the heel so their blood can be tested for dozens of life-threatening genetic and metabolic problems.

14 Sep 2022

Manuka honey could cure serious lung infections caused by drug-resistant bacterium

In a recent study published in the journal Microbiology, researchers demonstrated that incorporating Manuka honey into nebulized antibiotic treatment could effectively combat respiratory infections due to Mycobacterium abscessusus, offering a novel new therapeutic strategy for M. abscessus management.

13 Sep 2022

First-of-its-kind messenger RNA therapy developed for ovarian cancer, cachexia

Researchers at Oregon State University and Oregon Health & Science University have developed a promising, first-of-its-kind messenger RNA therapy for ovarian cancer as well as cachexia, a muscle-wasting condition associated with cancer and other chronic illnesses.

13 Sep 2022

Experts join forces to create a gold standard document to help people with cystic fibrosis

World leading experts have joined forces to create a gold standard document to help people living with Cystic Fibrosis.

7 Sep 2022

Combination therapy regimen for cystic fibrosis is also beneficial to primary school-aged children

Cystic fibrosis remains an incurable genetic disorder which impairs lung function and significantly reduces life expectancy.

8 Aug 2022

Study finds disparities in first evaluation of infants with cystic fibrosis from minoritized groups

Infants from minoritized racial and ethnic backgrounds who have positive newborn screening tests for cystic fibrosis received their diagnostic follow-up for the disease later than recommended and later than white, non-Hispanic infants, according to a study published in the Journal of Cystic Fibrosis.

27 Jul 2022

Parents become drug developers to save their children’s lives

Maggie Carmichael wasn't developing like other kids. As a toddler, she wasn't walking and had a limited vocabulary for her age.

21 Jul 2022

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

Forget covid-19, monkeypox, and other viruses for the moment and consider another threat troubling infectious disease specialists: common urinary tract infections, or UTIs, that lead to emergency room visits and even hospitalizations because of the failure of oral antibiotics.

15 Jul 2022

BU researcher wins Cystic Fibrosis Foundation's Harry Shwachman Clinical Investigator Award

Andrew Berical, MD, Assistant Professor of Medicine at Boston University School of Medicine (BUSM), is the recipient of the Harry Shwachman Clinical Investigator Award from the Cystic Fibrosis Foundation (CFF).

12 Jul 2022

Emory researchers identify key immune cell type that drives the transition from early to late COVID-19

Determining how SARS-CoV-2, the virus causing COVID-19, moves from an early stage of infection, when patients are largely asymptomatic, into a later stage when people may experience life-threatening inflammation in the lungs, is a critical step in understanding how to target and treat the disease more efficiently.

14 Jun 2022

Using a harmless amoeba to protect children from dangerous infections

Innovative efforts at the University of Virginia School of Medicine to use a harmless amoeba to protect children from dangerous infections has won critical financial support from The Hartwell Foundation.

10 Jun 2022

Cryo-EM helps scientists to decipher the structure of a key part of RNA degradation machinery

In biology, getting rid of stuff can be just as important as making it. A buildup of cells, proteins, or other molecules that are no longer needed can cause problems, so living things have evolved several ways to clean house.

9 Jun 2022

Largest-ever series of case studies shows phage therapy’s success in more than half of the patients

The number of reported cases using viruses to treat deadly Mycobacterium infections just went up by a factor of five. In a new study, a team led by researchers from the University of Pittsburgh and the University of California San Diego report 20 new case studies on the use of the experimental treatment, showing the therapy's success in more than half of the patients.

9 Jun 2022

Inhibiting immune response-related enzyme holds promise in preventing or treating severe COVID-19

Blocking an immune response-related enzyme holds promise in preventing or treating severe COVID-19 symptoms by reducing inflammation, tissue injury and blood clots in the lungs, new research in mice suggests.

1 Jun 2022

Cystic Fibrosis News and Research

Latest Cystic Fibrosis News and Research

Clinical trial to test the safety, efficacy of bacteriophages for treating P. aeruginosa infections in CF patients

Early-stage clinical trial evaluating bacteriophage therapy in adults with cystic fibrosis begins

Immune cell defect tied to the risk of developing rare bacterial infection

Learning health system approach offers a powerful route to improving NHS efficiency, report suggests

Vitamin supplements can benefit cystic fibrosis patients, study suggests

Investing in the next generation of researchers, Beckman Coulter Life Sciences announces call for grant applications

Newborns get routine heel blood tests, but should states keep those samples

Manuka honey could cure serious lung infections caused by drug-resistant bacterium

First-of-its-kind messenger RNA therapy developed for ovarian cancer, cachexia

Experts join forces to create a gold standard document to help people with cystic fibrosis

Combination therapy regimen for cystic fibrosis is also beneficial to primary school-aged children

Study finds disparities in first evaluation of infants with cystic fibrosis from minoritized groups

Parents become drug developers to save their children’s lives

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

BU researcher wins Cystic Fibrosis Foundation's Harry Shwachman Clinical Investigator Award

Emory researchers identify key immune cell type that drives the transition from early to late COVID-19

Using a harmless amoeba to protect children from dangerous infections

Cryo-EM helps scientists to decipher the structure of a key part of RNA degradation machinery

Largest-ever series of case studies shows phage therapy’s success in more than half of the patients

Inhibiting immune response-related enzyme holds promise in preventing or treating severe COVID-19

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Cystic Fibrosis News and Research

Latest Cystic Fibrosis News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in